[Tumor-induced rickets/osteomalacia].
Fukumoto
Seiji
S
Division of Nephrology & Endocrinology, Department of Medicine, University of Tokyo Hospital.
D000818:Animals; D002762:Cholecalciferol / Q000008:administration & dosage; D003937:Diagnosis, Differential; D000089703:Fibroblast Growth Factor-23; D005346:Fibroblast Growth Factors / Q000235:genetics / Q000502:physiology; D006801:Humans; D017674:Hypophosphatemia / Q000209:etiology; D009369:Neoplasms / Q000150:complications* / Q000601:surgery; D010018:Osteomalacia / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D010257:Paraneoplastic Syndromes / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy; D011379:Prognosis; D012279:Rickets / Q000175:diagnosis / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy
D002762:Cholecalciferol; D005346:Fibroblast Growth Factors; D000089703:Fibroblast Growth Factor-23